TWI511702B - Methods for the measurement of endothelial cell dilatation - Google Patents
Methods for the measurement of endothelial cell dilatation Download PDFInfo
- Publication number
- TWI511702B TWI511702B TW098142503A TW98142503A TWI511702B TW I511702 B TWI511702 B TW I511702B TW 098142503 A TW098142503 A TW 098142503A TW 98142503 A TW98142503 A TW 98142503A TW I511702 B TWI511702 B TW I511702B
- Authority
- TW
- Taiwan
- Prior art keywords
- pressure
- value
- endothelial cell
- airbag
- change
- Prior art date
Links
- 210000002889 endothelial cell Anatomy 0.000 title claims description 33
- 238000000034 method Methods 0.000 title claims description 26
- 238000005259 measurement Methods 0.000 title description 12
- 230000008859 change Effects 0.000 claims description 48
- 210000004204 blood vessel Anatomy 0.000 claims description 37
- 230000010261 cell growth Effects 0.000 claims description 36
- 206010020565 Hyperaemia Diseases 0.000 claims description 33
- 208000022064 reactive hyperemia Diseases 0.000 claims description 32
- 230000002792 vascular Effects 0.000 claims description 32
- 230000000747 cardiac effect Effects 0.000 claims description 26
- 230000036724 intravesical pressure Effects 0.000 claims description 17
- 210000003556 vascular endothelial cell Anatomy 0.000 claims description 10
- 238000003825 pressing Methods 0.000 claims description 7
- 230000000903 blocking effect Effects 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000004865 vascular response Effects 0.000 claims 1
- 230000006870 function Effects 0.000 description 27
- 210000002321 radial artery Anatomy 0.000 description 14
- 210000001367 artery Anatomy 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000008602 contraction Effects 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 2
- 206010053648 Vascular occlusion Diseases 0.000 description 2
- 210000002302 brachial artery Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 230000035485 pulse pressure Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000021331 vascular occlusion disease Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008694 endothelial dysfunction Effects 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000006499 vasodilator function Effects 0.000 description 1
Landscapes
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Description
本發明是有關於一種量測方法,特別是指一種內皮細胞擴張功能的量測方法。The present invention relates to a measuring method, and more particularly to a method for measuring the function of endothelial cell expansion.
動脈血管內壁上的內皮細胞(Endothelium)之擴張功能會影響動脈血管的擴張程度,因此一些內皮細胞擴張功能之量測研究已被提出,並作為評估血管動脈彈性之依據,再藉由動脈血管之彈性程度來推論發生心血管疾病的可能性及作為預防該疾病的指標。The expansion function of endothelial cells (Endothelium) on the inner wall of arterial vessels affects the degree of expansion of arterial blood vessels. Therefore, some studies on the expansion function of endothelial cells have been proposed and used as a basis for assessing the elasticity of vascular arteries, and then by arterial vessels. The degree of elasticity is used to infer the possibility of developing cardiovascular disease and as an indicator for preventing the disease.
在論文‘John E.Deanfield,Julian P.Halcox and Ton J.Rabelink,“Endothelial Function and Dysfunction:Testing and Clinical Relevance,”Circulation,115:1285-1295,2007.’提出一種以超音波技術來測量血管內皮細胞的(Endothelial)血流調節擴張功能(Flow-mediated dilatation,FMD)之方法,惟該超音波技術具有以下缺點:In the paper 'John E. Deanfield, Julian P. Halcox and Ton J. Rabelink, "Endothelial Function and Dysfunction: Testing and Clinical Relevance," Circulation, 115: 1285-1295, 2007. 'Proposed a method for measuring blood vessels by ultrasonic technology The method of Endothelial Flow-mediated Dilatation (FMD), which has the following disadvantages:
(一)須仰賴一套設備昂貴的高頻率超音波儀器,才能測量出血管的內部直徑。(1) The internal diameter of the blood vessel must be measured by relying on a high-frequency ultrasonic instrument with an expensive equipment.
(二)須藉由一位熟綀的醫生或者技術員,才能正確操作該儀器。(2) The instrument must be operated correctly by a skilled doctor or technician.
(三)須在專業的醫療院所才能進行該測量,無法達到一般居家之普及使用。(3) The measurement must be carried out in a professional medical institution and cannot be used universally.
(四)由於利用高頻率超音波來測量動脈的內皮細胞擴張功能指標時,因受限於測量血管口徑之準確度,而大 大降低該內皮細胞擴張功能指標之準確度及可靠度。(4) Due to the use of high-frequency ultrasound to measure the endothelial cell expansion function index of the artery, it is limited by the accuracy of measuring the blood vessel diameter. Greatly reduce the accuracy and reliability of the endothelial cell expansion function index.
(五)因受制於血管阻斷前後所產生血管口徑的變化量不大,導致由高頻率超音波所測得的內皮細胞擴張功能指標,其靈敏度不夠高。(5) The amount of change in the diameter of the blood vessels caused by the vascular occlusion before and after the vascular occlusion is small, resulting in the endothelial cell expansion function index measured by high-frequency ultrasound, and its sensitivity is not high enough.
因此,本發明之目的,即在提供一種避免上述缺失、降低設備成本和提高靈敏度的內皮細胞擴張功能量測方法。Accordingly, it is an object of the present invention to provide a method for measuring endothelial cell expansion function which avoids the above-mentioned deficiency, reduces equipment cost, and improves sensitivity.
內皮細胞擴張功能的量測方法,藉由一氣囊對一受測者肢體之一施壓來量測血管內皮細胞的擴張功能,且包含以下步驟:將該氣囊的內部氣體壓力設定為一低壓預設值,以對該受測者該肢體之一進行施壓;量測該氣囊內的氣壓以得到一血管常態期之氣囊內壓變化量;將該氣囊的內部氣體壓力設定為一高壓預設值,以對該受測者該肢體之一進行施壓;進而將該氣囊洩壓至該低壓預設值後,量測該氣囊內的氣壓以得到一血管反應性充血期之氣囊內壓變化量;比較該血管反應性充血期之氣囊內壓變化量與該血管常態期之氣囊內壓變化量以得到一差異值;及將該差異值除以該血管常態期之氣囊內壓變化量以得到一血管內皮細胞擴張功能的指標值。A method for measuring the function of endothelial cell expansion, which measures the expansion function of vascular endothelial cells by applying pressure to one of the limbs of a subject, and includes the following steps: setting the internal gas pressure of the balloon to a low pressure pre-pre Setting a value to apply pressure to one of the limbs of the subject; measuring the air pressure in the airbag to obtain a change in the internal pressure of the balloon during a normal period of the blood vessel; setting the internal gas pressure of the airbag to a high pressure preset a value for applying pressure to one of the limbs of the subject; and then depressing the balloon to the preset value of the low pressure, measuring the air pressure in the balloon to obtain a change in the intravesical pressure of the vascular reactive hyperemia period Comparing the amount of change in the intravesical pressure of the vascular reactive hyperemia period with the amount of change in the intravesical pressure of the normal period of the blood vessel to obtain a difference value; and dividing the difference value by the amount of change in the internal pressure of the balloon during the normal period of the blood vessel An index value for the expansion function of a vascular endothelial cell is obtained.
本發明之另一目的,即在提供一種避免上述缺失、和降低設備成本和提高靈敏度的內皮細胞擴張功能細胞擴張量測裝置。Another object of the present invention is to provide an endothelial cell expansion functional cell expansion measuring device which avoids the above-mentioned deficiency, and which reduces equipment cost and sensitivity.
內皮細胞擴張功能的量測裝置,適用於量測一受測者肢體之一的血管內皮細胞的擴張功能,且包含:一氣囊,包覆該受測者肢體之一且用於對該受測者肢體之一施壓;一氣壓調整電路,連接於該氣囊上且受控制以改變該氣囊之內部氣體壓力;一氣壓感測電路,連接於該氣囊上且用以量測該氣囊內的氣壓;及一處理器,電連接於該氣壓調整電路和該氣壓感測電路,且控制該氣壓調整電路將該氣囊的內部氣體壓力設定為一低壓預設值,以對該受測者肢體之一進行施壓,且接收該氣壓感測電路量測該氣囊時所得到的一血管常態期之氣囊內壓變化量;又該處理器更控制該氣壓調整電路將該氣囊的內部氣體壓力設定為一高壓預設值,以對該受測者肢體之一進行施壓,進而再控制該氣壓調整電路對該氣囊進行洩壓至該低壓預設值後,接收該氣壓感測電路量測該氣囊內的氣壓時所得到的一血管反應性充血期之氣囊內壓變化量;又該處理器更比較該血管反應性充血期之氣囊內壓變化量與該血管常態期之氣囊內壓變化量以得到一差異值;進而該處理器將該差異值除以該血管常態期之氣囊內壓變化量以得到一血管內皮細胞擴張功能的指標值。A measuring device for endothelial cell expansion function, which is suitable for measuring the expansion function of vascular endothelial cells of one of the limbs of a subject, and comprising: an air bag covering one of the limbs of the subject and used for the test Applying pressure to one of the limbs; a gas pressure adjusting circuit coupled to the air bag and controlled to change the internal gas pressure of the air bag; a pneumatic sensing circuit coupled to the air bag for measuring the air pressure in the air bag And a processor electrically connected to the air pressure adjusting circuit and the air pressure sensing circuit, and controlling the air pressure adjusting circuit to set the internal gas pressure of the airbag to a low pressure preset value, to one of the limbs of the subject Applying pressure, and receiving the air pressure sensing circuit to measure the airbag internal pressure change amount of a normal period of the blood vessel obtained by measuring the airbag; and the processor further controls the air pressure adjusting circuit to set the internal gas pressure of the airbag to one The high pressure preset value is used to apply pressure to one of the limbs of the subject, and then control the air pressure adjusting circuit to release the airbag to the low voltage preset value, and receive the air pressure sensing circuit to measure the The amount of change in the intravesical pressure of a vascular reactive hyperemia period obtained during the pressure in the capsule; and the processor compares the amount of change in the intravesical pressure of the vascular reactive hyperemia period with the change in the internal pressure of the balloon during the normal period of the vascular To obtain a difference value; the processor further divides the difference value by the change in the intravesical pressure of the vascular normal period to obtain an index value of the vascular endothelial cell expansion function.
有關本發明之前述及其他技術內容、特點與功效,在以下配合參考圖式之一個較佳實施例的詳細說明中,將可清楚的呈現。The above and other technical contents, features and advantages of the present invention will be apparent from the following detailed description of the preferred embodiments.
如圖1所示,本發明內皮細胞擴張功能量測裝置之較佳實施例,利用一氣囊袋或脈壓袋包覆在一受測者肢體(雙手或雙腳)之一的上半部或下半部,並充氣加壓該氣囊袋或脈壓袋,使其施壓於所包覆的肢體部位,進而量測內皮細胞擴張的功能,以進行早期血管硬化的評估,且包含:一氣囊5、一氣壓調整電路6、一處理器7、一氣壓感測電路8和一螢幕9。As shown in FIG. 1, a preferred embodiment of the endothelial cell expansion function measuring device of the present invention is coated with an airbag bag or a pulse pressure bag to cover the upper half of one of the subject's limbs (both hands or feet). Or the lower half, and inflating and pressing the airbag bag or the pulse pressure bag to apply pressure to the covered limb part, thereby measuring the function of endothelial cell expansion for evaluation of early arteriosclerosis, and includes: The air bag 5, a gas pressure adjusting circuit 6, a processor 7, a gas pressure sensing circuit 8, and a screen 9.
氣囊5包覆該受測者之上臂上,且與該氣壓調整電路6和氣壓感測電路8相連接。The airbag 5 covers the upper arm of the subject and is connected to the air pressure adjusting circuit 6 and the air pressure sensing circuit 8.
處理器7電連接於該氣壓調整電路6、氣壓感測電路8和螢幕9之間。The processor 7 is electrically connected between the air pressure adjusting circuit 6, the air pressure sensing circuit 8, and the screen 9.
氣壓調整電路6包括一數位類比轉換器61、一幫浦控制器62和一幫浦63。The air pressure adjusting circuit 6 includes a digital analog converter 61, a pump controller 62, and a pump 63.
數位類比轉換器61電連接於該處理器7和幫浦控制器62之間,幫浦63電連接於幫浦控制器62和氣囊5之間。The digital analog converter 61 is electrically connected between the processor 7 and the pump controller 62, and the pump 63 is electrically connected between the pump controller 62 and the airbag 5.
氣壓感測電路8包括一感測器81、一帶通濾波器82、一放大器83和一類比數位轉換器84。The air pressure sensing circuit 8 includes a sensor 81, a band pass filter 82, an amplifier 83, and an analog digital converter 84.
感測器81連接於該氣囊5和帶通濾波器82之間,放大器83連接於該類比數位轉換器84和帶通濾波器82之間,類比數位轉換器84電連接於該放大器83和處理器7之間。The sensor 81 is connected between the air bag 5 and the band pass filter 82, and the amplifier 83 is connected between the analog bit converter 84 and the band pass filter 82. The analog bit converter 84 is electrically connected to the amplifier 83 and processed. Between the 7th.
參閱圖1及圖2,內皮細胞擴張功能量測裝置執行一種內皮細胞擴張功能的量測方法,該內皮細胞擴張功能量測方法包含以下步驟:Referring to Figures 1 and 2, the endothelial cell expansion function measuring device performs a measurement method of endothelial cell expansion function, and the endothelial cell expansion function measurement method comprises the following steps:
步驟1:處理器7控制氣壓調整電路6將該氣囊5的內部氣體壓力設定為一低壓預設值,以對該受測者之上臂進行施壓,且進而藉由氣壓感測電路8量測該氣囊5內的氣壓以得到一血管常態期之氣囊內壓變化量。Step 1: The processor 7 controls the air pressure adjusting circuit 6 to set the internal gas pressure of the airbag 5 to a low pressure preset value to apply pressure to the upper arm of the subject, and then measure by the air pressure sensing circuit 8. The air pressure in the air bag 5 is used to obtain a change in the internal pressure of the airbag in a normal period of the blood vessel.
其中,血管常態期之氣囊內壓變化量的物理意義為:因為受測者之上臂血壓增減將造成血管體積的增減,進而使氣囊5之體積成反比變化,而氣囊5之體積的變化又將造成氣囊5的內部氣體壓力以該低壓預設值為準位上下變化,而此上下變化的值就是該血管常態期之氣囊內壓變化量,又在本實施例中,該低壓預設值的最佳範圍爲30~60毫米汞柱。Among them, the physical meaning of the change of the internal pressure of the balloon during the normal period of the blood vessel is as follows: because the blood pressure increase and decrease of the upper arm of the subject will increase or decrease the volume of the blood vessel, thereby causing the volume of the airbag 5 to be inversely changed, and the volume of the airbag 5 is changed. Moreover, the internal gas pressure of the airbag 5 is changed up and down by the preset value of the low pressure, and the value of the up and down change is the amount of change of the internal pressure of the airbag in the normal state of the blood vessel. In the embodiment, the low pressure preset The optimum range of values is 30 to 60 mm Hg.
參閱圖1及圖3,步驟1包括以下子步驟:Referring to Figures 1 and 3, step 1 includes the following sub-steps:
步驟11:處理器7發出一用於致能的數位控制信號到該氣壓調整電路6。Step 11: The processor 7 sends a digital control signal for enabling to the air pressure adjusting circuit 6.
步驟12:氣壓調整電路6接收該用於致能的數位控制信號,並根據該數位控制信號而使該氣囊5的內部氣體壓力由0遞增。Step 12: The air pressure adjusting circuit 6 receives the digital control signal for enabling, and increases the internal gas pressure of the airbag 5 by 0 according to the digital control signal.
其中,於步驟12中使壓力由0遞增的詳細做法為:數位類比轉換器61將所接收的數位控制信號轉換成一具有致能電壓準位的類比控制信號提供給幫浦控制器62,使幫浦控制器62發出一加壓信號以使幫浦63提供一加壓機械力,該加壓機械力造成該氣囊5的內部氣體壓力由0遞增。The detailed method of increasing the pressure from 0 in step 12 is: the digital analog converter 61 converts the received digital control signal into an analog control signal having an enabled voltage level, and supplies it to the pump controller 62. The purge controller 62 sends a pressurization signal to cause the pump 63 to provide a pressurized mechanical force that causes the internal gas pressure of the bladder 5 to increase by zero.
步驟13:氣壓感測電路8對該氣囊5內的氣壓進行量測以得到一特定週期氣壓值的數位量測信號。Step 13: The air pressure sensing circuit 8 measures the air pressure in the airbag 5 to obtain a digital measurement signal of a specific period air pressure value.
其中,於步驟13中對該氣囊5內的氣壓進行量測的詳細做法為:感測器81將所量測到的氣壓值轉換成一電壓信號,該電壓信號先經過帶通濾波器82濾除雜訊,再經由該放大器83將該電壓信號之振幅放大以得到一類比量測信號,進而該類比量測信號於該特定週期中的之振幅值經由該類比數位轉換器84轉換成該具有該特定週期氣壓值的數位量測信號,其中,在本實施例中,該特定週期的最佳範圍為1~3個心週期,且帶通濾波器82的最佳頻寬範圍為0.01Hz~30Hz之間。The detailed measurement of the air pressure in the airbag 5 in step 13 is: the sensor 81 converts the measured air pressure value into a voltage signal, and the voltage signal is first filtered by the band pass filter 82. The noise is amplified by the amplifier 83 to obtain an analog measurement signal, and the amplitude value of the analog measurement signal in the specific period is converted to the same by the analog-to-digital converter 84. The digital measurement signal of the specific period air pressure value, wherein, in the embodiment, the optimal range of the specific period is 1 to 3 cardiac periods, and the optimal bandwidth of the band pass filter 82 is 0.01 Hz to 30 Hz. between.
步驟14:處理器7接收該特定週期氣壓值的數位量測信號,且於根據該特定週期氣壓值以估算出一平均氣壓值,且比較該平均氣壓值是否達到該低壓預設值,若否,則回到步驟11,若是則進到步驟15。Step 14: The processor 7 receives the digital measurement signal of the specific period air pressure value, and estimates an average air pressure value according to the specific period air pressure value, and compares whether the average air pressure value reaches the low pressure preset value, and if not Then, return to step 11, and if yes, proceed to step 15.
步驟15:處理器7發出一用於暫停的數位控制信號到該氣壓調整電路6,且根據氣壓值中相對於每一個心週期的極大值與最小值之差異值作為該血管常態期氣囊內壓變化量。Step 15: The processor 7 sends a digital control signal for pause to the air pressure adjusting circuit 6, and according to the difference value between the maximum value and the minimum value of each of the cardiac cycles, the internal pressure of the blood vessel is normal. The amount of change.
其中步驟15的詳細做法為:處理器7找出在一血管常態期間內該氣壓值在每一心週期中相對的極高值與極低值,以計算出該氣壓值在每一心週期中相對的極高值與極低值以得到每一心週期的氣囊內壓差異值,更找出各心週期的氣囊內壓差異值中較穩定且連續之多數個心週期氣囊內壓差異值,進而將該多數個心週期氣囊內壓差異值之平均值作為該血管常態期之氣囊內壓變化量,其中,該血管常態期間的最佳範圍為3~30秒,又值得注意的是該較穩定且連續之多數個心週期氣囊內壓差異值,係指在血管常態期間,具有相對較穩定且連續之3~15個心週期氣囊內壓差異值。The detailed method of step 15 is: the processor 7 finds the relative high value and the extremely low value of the air pressure value in each cardiac cycle during a normal state of the blood vessel to calculate the relative value of the air pressure value in each cardiac cycle. The extremely high value and the extremely low value are used to obtain the difference value of the internal pressure of the balloon in each cardiac cycle, and the difference value of the intracardial pressure of the most stable and continuous plurality of intracardial pressures in the intracardial pressure difference value of each cardiac cycle is further found, and the The average value of the intracardial pressure difference of the majority of the cardiac cycle is used as the change of the intravesical pressure of the normal period of the blood vessel, wherein the optimal range of the normal period of the blood vessel is 3 to 30 seconds, and it is worth noting that the stable and continuous The difference in the internal pressure of the balloon during the majority of the cardiac cycle refers to the relatively stable and continuous 3 to 15 cardiac cycle internal pressure difference values during the normal state of the blood vessel.
步驟16:氣壓調整電路6接收該用於暫停的數位控制信號,並根據該數位控制信號而不再對該氣囊加壓。Step 16: The air pressure adjusting circuit 6 receives the digital control signal for suspension and no longer pressurizes the airbag based on the digital control signal.
其中,於步驟16中不再對該氣囊加壓的詳細做法為:數位類比轉換器61將所接收的該用於暫停的數位控制信號轉換成一具有暫停電壓準位的類比控制信號提供給幫浦控制器62,使幫浦控制器62停止發出該加壓信號而使幫浦63不提供加壓機械力,以避免影響該氣囊5的內部氣體壓力。The detailed method of no longer pressurizing the airbag in step 16 is: the digital analog converter 61 converts the received digital control signal for pause into an analog control signal having a pause voltage level to be supplied to the pump. The controller 62 causes the pump controller 62 to stop issuing the pressurizing signal so that the pump 63 does not provide a pressurized mechanical force to avoid affecting the internal gas pressure of the air bag 5.
復參閱圖1及圖2,步驟2:處理器7控制該氣壓調整電路6將該氣囊5的內部氣體壓力設定為一高壓預設值,以對該受測者之上臂進行施壓,使該受測者之上臂血管於一高壓阻塞時間內血液無法流通,進而洩壓至一低壓預設值後於一反應性充血時間藉由氣壓感測電路8量測該氣囊5內的氣壓以得到一血管反應性充血期之氣囊內壓變化量。Referring to FIG. 1 and FIG. 2, step 2: the processor 7 controls the air pressure adjusting circuit 6 to set the internal gas pressure of the airbag 5 to a high pressure preset value to apply pressure on the upper arm of the subject, so that the The blood of the upper arm of the subject is unable to circulate during a high pressure blocking period, and then the pressure is released to a low pressure preset value, and the air pressure in the airbag 5 is measured by the air pressure sensing circuit 8 at a reactive hyperemia time to obtain a blood pressure. The amount of change in intravesical pressure during vascular reactive hyperemia.
又在本實施例中,上述高壓阻塞時間的最佳範圍為3~5分鐘內,該高壓預設值的最佳範圍爲150~200毫米汞柱,且反應充血時間的最佳範圍為3~15分鐘。In this embodiment, the optimal range of the high-pressure blocking time is 3 to 5 minutes, and the optimal range of the high-pressure preset value is 150 to 200 mmHg, and the optimal range of the reaction congestion time is 3~ 15 minutes.
參閱圖1及圖4,又該步驟2包括多數個子步驟21~26,該等子步驟21、23與步驟11、13相同,而步驟22與步驟12的差別為從該低壓預設值開始增壓,而子步驟24~26如下:Referring to FIG. 1 and FIG. 4, the step 2 includes a plurality of sub-steps 21~26. The sub-steps 21 and 23 are the same as steps 11 and 13, and the difference between step 22 and step 12 is increased from the low-voltage preset value. Press, and sub-steps 24~26 are as follows:
步驟24:處理器7接收該特定週期氣壓值的數位量測信號,且於根據該特定週期氣壓值以估算出一平均氣壓值,且比較該平均氣壓值是否達到該高壓預設值,若否,則回到步驟21,若是則進到步驟25。Step 24: The processor 7 receives the digital measurement signal of the specific period air pressure value, and estimates an average air pressure value according to the specific period air pressure value, and compares whether the average air pressure value reaches the high pressure preset value, and if not Then, return to step 21, and if yes, proceed to step 25.
步驟25:處理器7發出一用於暫停的數位控制信號到該氣壓調整電路6。Step 25: The processor 7 sends a digital control signal for the pause to the air pressure adjustment circuit 6.
步驟26:氣壓調整電路6接收該用於暫停的數位控制信號,並根據該用於暫停的數位控制信號而不再對該氣囊5加壓。Step 26: The air pressure adjusting circuit 6 receives the digital control signal for the pause and no longer pressurizes the airbag 5 based on the digital control signal for the pause.
步驟27:於該高壓阻塞時間後,處理器7發出一用於洩壓的數位控制信號到該氣壓調整電路6。Step 27: After the high voltage blocking time, the processor 7 sends a digital control signal for releasing the pressure to the air pressure adjusting circuit 6.
步驟28:氣壓調整電路6接收該用於洩壓的數位控制信號,並根據該用於洩壓的數位控制信號而使該氣囊5由高壓預設值洩壓至該低壓預設值。Step 28: The air pressure adjusting circuit 6 receives the digital control signal for pressure relief, and depressurizes the airbag 5 from the high voltage preset value to the low voltage preset value according to the digital control signal for pressure relief.
其中,於步驟28中使該氣囊5洩壓的詳細做法為:數位類比轉換器61將所接收的該用於洩壓的數位控制信號轉換成一具有洩壓準位的類比控制信號提供給幫浦控制器62,使幫浦控制器62發出該洩壓信號而使幫浦63提供一洩壓機械力,該洩壓機械力造成該氣囊5的內部氣體壓力由高壓預設值遞減,直到該氣壓量測信號的平均值等達到低壓預設值時,處理器7發出一用於暫停的數位控制信號使該調整氣壓電路6停止對該氣囊5洩壓。The detailed method of releasing the airbag 5 in step 28 is as follows: the digital analog converter 61 converts the received digital control signal for pressure relief into an analog control signal having a pressure relief level and provides the pump with an analog control signal. The controller 62 causes the pump controller 62 to emit the pressure relief signal to cause the pump 63 to provide a pressure relief mechanical force, which causes the internal gas pressure of the airbag 5 to be decremented from the high pressure preset value until the air pressure When the average value of the measurement signal or the like reaches the low voltage preset value, the processor 7 issues a digital control signal for the pause to cause the adjustment air pressure circuit 6 to stop releasing the pressure on the air bag 5.
步驟29:於高壓阻塞時間後,氣壓感測電路8量測該氣囊內的氣壓以得到一具有血管反應性充血期氣壓值的數位量測信號(因為類似步驟13,故在此不再纍述),並計算該血管反應性充血期中氣壓值的極大值與極小值之差異值,且以該血管反應性充血期中相對較大且連續之3~15個心週期氣囊內壓差異值之平均值作為該血管反應性充血期之氣囊內壓變化量△PC ,因為得到血管反應性充血期之氣囊內壓變化量的詳細作法類似步驟15,故在此不再纍述。Step 29: After the high pressure blocking time, the air pressure sensing circuit 8 measures the air pressure in the airbag to obtain a digital measurement signal having a blood pressure value of the vascular reactive hyperemia period (because similar to step 13, it is not repeated here) And calculating the difference between the maximum value and the minimum value of the blood pressure value in the vascular reactive hyperemia period, and the average value of the difference between the internal pressure of the relatively large and continuous 3 to 15 cardiac cycles in the vascular reactive hyperemia period The amount of change in the intra-balloon pressure ΔP C of the vascular reactive hyperemia period is similar to the step 15 in that the amount of change in the intra-balloon pressure of the vascular reactive hyperemia period is similar, and therefore will not be described here.
又在該血管反應性充血期結束後,由該處理器控制該氣壓調整電路對該氣囊進行洩壓並比較該平均氣壓值是否達到0毫米汞柱左右,若是則停止洩壓,否則繼續洩壓直到該平均氣壓值達到該0毫米汞柱左右。After the end of the vascular reactive hyperemia period, the air pressure adjusting circuit is controlled by the processor to depressurize the airbag and compare whether the average air pressure value reaches about 0 mmHg. If yes, stop the pressure release, otherwise continue to relieve pressure. Until the average pressure value reaches about 0 mmHg.
復參閱圖1及圖2,步驟3:處理器7比較該血管反應性充血期之氣囊內壓變化量△PC 與該血管常態期之氣囊內壓變化量△PC,0 以得到一差異值(△PC -△PC,0 )。Referring to FIG. 1 and FIG. 2, step 3: processor 7 compares the change of the intra-balloon pressure ΔP C of the vascular reactive hyperemia period with the change of the intra-vessel pressure of the vascular normal period ΔP C, 0 to obtain a difference. Value (ΔP C - ΔP C, 0 ).
步驟4:處理器7將該差異值(△PC -△PC,0 )除以該血管常態期之氣囊內壓變化量△PC,0 以得到一血管內皮細胞擴張功能的指標值(FMDC ),如式(1)所示,且將該血管內皮細胞擴張功能的指標值顯示於該螢幕9上。此外,也可重複此量測流程,處理器7在計算出該血管常態期及該血管反應性充血期間之各心週期的氣囊內壓變化量之後,便可得到一該血管常態期間及該血管反應性充血期間之隨時間變化的相對性血管體積變化波形,而可於螢幕9上顯示出一張隨時間變化的血管體積變化波形,且該處理器在計算出該血管反應性充血期間之各心週期的氣囊內壓變化量並除以該血管常態期之氣囊內壓變化量的平均值之後,便可得到一在血管反應性充血期間隨時間變化的內皮細胞擴張功能指標值的波形,而可於螢幕9上顯示出一張隨時間變化的血管反應性充血期間內皮細胞擴張功能指標的波形。Step 4: The processor 7 difference value (△ P C - △ P C , 0) divided by the balloon inside the pressure vessel of the normal amount of change △ P C, 0 to obtain an index value of vascular endothelial vasodilator function ( FMD C ), as shown in the formula (1), and the index value of the vascular endothelial cell expansion function is displayed on the screen 9. In addition, the measurement process may be repeated, and the processor 7 may obtain a normal period of the blood vessel and the blood vessel after calculating the amount of change in the balloon internal pressure of each cardiac cycle during the normal period of the blood vessel and the vascular reactive hyperemia period. A waveform of relative vessel volume change over time during reactive hyperemia, and a waveform of changes in vessel volume over time can be displayed on screen 9, and the processor calculates each period of vascular reactive hyperemia After the change in the intravesical pressure of the cardiac cycle is divided by the average value of the change in the intravesical pressure of the normal phase of the blood vessel, a waveform of the endothelial cell expansion function index value which changes with time during the vascular reactive hyperemia is obtained, and A waveform of endothelial cell expansion function index during vascular reactive hyperemia over time can be displayed on the screen 9.
其中FMDC 的物理意義是指由氣囊5所推測的血管內皮細胞擴張功能的指標值,且常態內壓變化量△PC,0 的物理意義是指在高壓阻塞前血管常態期下氣囊內壓的最大振盪變動量。The physical meaning of FMD C refers to the index value of the vascular endothelial cell expansion function estimated by the balloon 5, and the physical value of the normal internal pressure change ΔP C, 0 refers to the intravascular balloon pressure before the high pressure occlusion. The maximum amount of oscillation variation.
如圖5、6所示,將一寬度為L的氣囊環繞於上臂時,氣囊5的內壓與體積之間成一非線性的關係,但是當氣囊的內壓維持在一較低的壓力時,且當其內壓變動或振盪極小時,則很明顯地在此狹窄範圍內的氣囊內壓與體積之間的關係,可視為是近似線性的。又肱動脈中的血液和介於肱動脈及氣囊之間的組織是屬於較不可壓縮的(Incompressable)物質,而氣囊袋中的空氣是屬於很容易被壓縮的(Compressable)的物質。將具有一固定低氣壓(30~60毫米汞柱之間)的氣囊環繞於上臂時,由於氣囊和動脈之間的交互作用(如圖6),肱動脈的體積在最大收縮點(A1)和最大擴張點(A2)時所產生的體積變化量(即△Va=Va,max-Va,min),會直接反映在氣囊5的體積變化上,也就是氣囊體積的最大擴張點(B1)應該要相對於血管的最大收縮點,而氣囊體積的最大收縮點(B2)應該要相對於肱動脈的最大擴張點,故有一定比例的肱動脈體積變化量會反映在氣囊體積的變化量(△Vc=Vc,max-Vc,min)上,如式(2)。As shown in FIGS. 5 and 6, when an airbag having a width L is wrapped around the upper arm, the internal pressure of the airbag 5 is in a non-linear relationship with the volume, but when the internal pressure of the airbag is maintained at a low pressure, And when the internal pressure changes or the oscillation is extremely small, it is obvious that the relationship between the internal pressure of the balloon and the volume within the narrow range can be regarded as approximately linear. The blood in the radial artery and the tissue between the radial artery and the balloon are incompressible substances, and the air in the airbag bag is a Compressable substance. When an airbag with a fixed low air pressure (between 30 and 60 mm Hg) is wrapped around the upper arm, the volume of the radial artery is at the maximum contraction point (A1) due to the interaction between the balloon and the artery (Fig. 6). The volume change (ie ΔVa=Va,max-Va,min) generated at the maximum expansion point (A2) is directly reflected in the volume change of the airbag 5, that is, the maximum expansion point (B1) of the airbag volume should be The maximum contraction point relative to the blood vessel, and the maximum contraction point (B2) of the balloon volume should be relative to the maximum expansion point of the radial artery, so a certain proportion of the radial artery volume change will be reflected in the volume change of the balloon (△ Vc = Vc, max - Vc, min), as in equation (2).
ΔVc =α (ΔVa ) .....................................(2)Δ Vc = α (Δ Va ) .....................................(2)
其中α為一比例常數,位在0和1之間。由於在一個低內壓的氣囊5中,當其體積變動很小時,則壓力變動量(△Pc)與體積變動量之間的關係可視為一正比例的關係,如式(3)。Where α is a proportional constant between 0 and 1. Since the volume fluctuation amount (ΔPc) and the volume variation amount are small in the case of the airbag 5 having a low internal pressure, the relationship between the pressure fluctuation amount (ΔPc) and the volume variation amount can be regarded as a proportional relationship, as in the equation (3).
其中Cc為該氣囊5在此低壓時的順應性(Compliance),且在此窄範圍的變動量之內,Cc可視為一固定值。Where Cc is the compliance of the airbag 5 at this low pressure, and within this narrow range of variation, Cc can be regarded as a fixed value.
而△VC 是阻斷後肱動脈產生反應性充血期之氣囊內壓的最大振盪變動量。將公式(1)中的△PC 及△PC,0 ,分別依公式(3)代入後,可推得式(4)ΔV C is the maximum oscillation variation of the intravesical pressure during the reactive hyperemia period after the blockage of the brachial artery. By substituting ΔP C and ΔP C,0 in the formula (1) according to the formula (3), the formula (4) can be derived.
又將式(4)中的△VC 及△VC,0 ,依據公式(2)代入後,可得到:Further, after ΔV C and ΔV C,0 in the formula (4) are substituted according to the formula (2), it is obtained:
故由公式(5)可得知,由氣囊5所計得的血管內皮細胞擴張功能指標值,其實是相當於肱動脈體積在阻塞前後之變化率。若將公式(5)中肱動脈變動的體積以直徑表示,則可推得式(6)。Therefore, it can be known from the formula (5) that the index value of the vascular endothelial cell expansion function counted by the balloon 5 is actually equivalent to the rate of change of the radial artery volume before and after the blockage. If the volume of the radial artery fluctuation in the formula (5) is expressed by the diameter, the formula (6) can be derived.
其中,L為氣囊袋的寬度,D0,max 為肱動脈在常態下的最大直徑,D0,min 為肱動脈在常態下的最小直徑,Dmax為肱動脈在阻塞後反應性充血期間最大的直徑,而Dmin為肱動脈在阻塞後反應性充血期間最小的直徑。將式(6)的分母分子同除以(Lπ/4)可簡化為如式(7)Where L is the width of the balloon bag, D 0,max is the maximum diameter of the radial artery in the normal state, D 0,min is the minimum diameter of the radial artery in the normal state, and Dmax is the largest during the reactive hyperemia of the radial artery after obstruction. Diameter, and Dmin is the smallest diameter of the radial artery during reactive hyperemia after occlusion. Dividing the denominator of formula (6) by (Lπ/4) can be simplified as equation (7)
假設在常態下及在阻塞後反應性充血期間,血管最小直徑的變化差異很小,可忽略不計(即D0,min ≒Dmin );又假設D2 0,max >>D2 0,min (只有在直徑有很大變動時才合理),則公式(7)可簡化成如式(8)It is assumed that during the normal state and during reactive hyperemia after occlusion, the difference in the minimum diameter of the blood vessel is small and negligible (ie D 0,min ≒D min ); it is also assumed that D 2 0,max >>D 2 0,min (only reasonable if there is a large change in diameter), then equation (7) can be simplified as equation (8)
其中,D0 為肱動脈在常態下的最大直徑,D為肱動脈在阻塞後反應性充血期間最大的直徑。Where D 0 is the maximum diameter of the radial artery under normal conditions, and D is the largest diameter of the radial artery during reactive hyperemia after obstruction.
又如下式(9)為利用高頻超音波來測量上臂肱動脈(或稱臂動脈)的內皮細胞擴張功能指標值(FMDU )之計算方式。Further, the following formula (9) is a method for calculating the endothelial cell expansion function index value (FMD U ) of the upper brachial artery (or arm artery) by using high-frequency ultrasonic waves.
將式(9)與式(8)作比較,可將公式(8)轉換如式(10)。Comparing equation (9) with equation (8), equation (8) can be converted to equation (10).
由式(10)可知,以氣囊5所測得的內皮細胞擴張功能指標之數值,遠大於以超音波所測得的內皮細胞擴張功能指標之數值。As can be seen from the formula (10), the value of the endothelial cell expansion function index measured by the balloon 5 is much larger than the value of the endothelial cell expansion function index measured by ultrasound.
綜上所述,本發明具有以下優點:In summary, the present invention has the following advantages:
(一)以氣囊5來取得所需的數值,相較於使用超音波的方式可降低成本。(1) The airbag 5 is used to obtain the required value, which can reduce the cost compared to the method of using ultrasonic waves.
(二)不需要熟綀的醫生或者技術員即可操作本發明,又可於一般場所使用,能增加普及程度。(2) The invention can be operated without a skilled doctor or technician, and can be used in a general place, which can increase the popularity.
(三)由式(10)知氣囊5方式相較於超音波方式,在量測內皮細胞擴張功能指標值時具有較高的靈敏度。(3) From the formula (10), the balloon 5 method has higher sensitivity when measuring the endothelial cell expansion function index value than the ultrasonic method.
惟以上所述者,僅為本發明之較佳實施例而已,當不能以此限定本發明實施之範圍,即大凡依本發明申請專利範圍及發明說明內容所作之簡單的等效變化與修飾,皆仍屬本發明專利涵蓋之範圍內。The above is only the preferred embodiment of the present invention, and the scope of the invention is not limited thereto, that is, the simple equivalent changes and modifications made by the scope of the invention and the description of the invention are All remain within the scope of the invention patent.
1‧‧‧量常態內壓的步驟1‧‧‧Steps of normal internal pressure
11‧‧‧致能的步驟11‧‧‧Enable steps
12‧‧‧增壓的步驟12‧‧‧Steps for boosting
13‧‧‧量測信號的步驟13‧‧‧Steps for measuring signals
14‧‧‧比較的步驟14‧‧‧Compare steps
15‧‧‧暫停的步驟15‧‧‧Steps to suspend
16‧‧‧停止加壓的步驟16‧‧‧Steps to stop pressurization
2‧‧‧量阻塞內壓的步驟2‧‧‧Steps for blocking internal pressure
21‧‧‧致能的步驟21‧‧‧Enable steps
22‧‧‧增壓的步驟22‧‧‧Steps for boosting
23‧‧‧量測信號的步驟23‧‧‧Steps for measuring signals
24‧‧‧比較的步驟24‧‧‧Compare steps
25‧‧‧暫停的步驟25‧‧‧Steps to suspend
26‧‧‧停止加壓的步驟26‧‧‧Steps to stop pressurization
27‧‧‧洩壓信號的步驟27‧‧‧Steps for relieving pressure signals
28‧‧‧進行洩壓的步驟28‧‧‧Steps for pressure relief
29‧‧‧得到充血內壓的步驟29‧‧‧Steps to get hyperemia
3‧‧‧算差異值的步驟3‧‧‧Steps for calculating the difference value
4‧‧‧算擴張值的步驟4‧‧‧Steps to calculate the expansion value
5‧‧‧氣囊5‧‧‧Airbag
6‧‧‧氣壓調整電路6‧‧‧Pneumatic adjustment circuit
61‧‧‧數位類比轉換器61‧‧‧Digital Analog Converter
62‧‧‧幫浦控制器62‧‧‧ pump controller
63‧‧‧幫浦63‧‧‧
7‧‧‧處理器7‧‧‧ Processor
8‧‧‧氣壓感測電路8‧‧‧Pneumatic sensing circuit
81‧‧‧感測器81‧‧‧ Sensor
82‧‧‧帶通濾波器82‧‧‧Bandpass filter
83‧‧‧放大器83‧‧‧Amplifier
84‧‧‧類比數位轉換器84‧‧‧ analog digital converter
9‧‧‧螢幕9‧‧‧ screen
圖1是本發明之較佳實施例的功能方塊圖;Figure 1 is a functional block diagram of a preferred embodiment of the present invention;
圖2是該較佳實施例的流程圖;Figure 2 is a flow chart of the preferred embodiment;
圖3是第一步驟中,子步驟的流程圖;Figure 3 is a flow chart of the sub-steps in the first step;
圖4是第二步驟中,子步驟的的流程圖;Figure 4 is a flow chart of the sub-steps in the second step;
圖5是氣囊環繞上臂的剖面示意圖;及Figure 5 is a schematic cross-sectional view of the airbag surrounding the upper arm;
圖6是氣囊與肱動脈交互作用的示意圖。Figure 6 is a schematic illustration of the interaction of the balloon with the radial artery.
5‧‧‧氣囊5‧‧‧Airbag
6‧‧‧氣壓調整電路6‧‧‧Pneumatic adjustment circuit
61‧‧‧數位類比轉換器61‧‧‧Digital Analog Converter
62‧‧‧幫浦控制器62‧‧‧ pump controller
63‧‧‧幫浦63‧‧‧
7‧‧‧處理器7‧‧‧ Processor
8‧‧‧氣壓感測電路8‧‧‧Pneumatic sensing circuit
81‧‧‧感測器81‧‧‧ Sensor
82‧‧‧帶通濾波器82‧‧‧Bandpass filter
83‧‧‧放大器83‧‧‧Amplifier
84‧‧‧類比數位轉換器84‧‧‧ analog digital converter
9‧‧‧螢幕9‧‧‧ screen
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW098142503A TWI511702B (en) | 2009-12-11 | 2009-12-11 | Methods for the measurement of endothelial cell dilatation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW098142503A TWI511702B (en) | 2009-12-11 | 2009-12-11 | Methods for the measurement of endothelial cell dilatation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201119622A TW201119622A (en) | 2011-06-16 |
| TWI511702B true TWI511702B (en) | 2015-12-11 |
Family
ID=45044881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW098142503A TWI511702B (en) | 2009-12-11 | 2009-12-11 | Methods for the measurement of endothelial cell dilatation |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI511702B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174291B1 (en) * | 1998-03-09 | 2001-01-16 | Spectrascience, Inc. | Optical biopsy system and methods for tissue diagnosis |
| TWI253923B (en) * | 2004-11-24 | 2006-05-01 | Hen-Hong Chang | Noninvasive sphygmus measurement method and system with constant pressure for extremity |
| TW200944177A (en) * | 2008-04-18 | 2009-11-01 | Hsien-Tsai Wu | A device and method for early blood vessel aging detection |
-
2009
- 2009-12-11 TW TW098142503A patent/TWI511702B/en not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174291B1 (en) * | 1998-03-09 | 2001-01-16 | Spectrascience, Inc. | Optical biopsy system and methods for tissue diagnosis |
| TWI253923B (en) * | 2004-11-24 | 2006-05-01 | Hen-Hong Chang | Noninvasive sphygmus measurement method and system with constant pressure for extremity |
| TW200944177A (en) * | 2008-04-18 | 2009-11-01 | Hsien-Tsai Wu | A device and method for early blood vessel aging detection |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201119622A (en) | 2011-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3957758B2 (en) | Non-invasive high-speed blood pressure measurement device | |
| JP3675764B2 (en) | Atherosclerosis inspection device | |
| US6814705B2 (en) | Arteriosclerosis-degree evaluating apparatus | |
| US5368039A (en) | Method and apparatus for determining blood pressure | |
| KR101460922B1 (en) | Non-invasive blood pressure measuring apparatus and measuring method thereof | |
| US8430822B2 (en) | Blood pressure measuring apparatus and method of controlling the same | |
| JP5337821B2 (en) | Method and apparatus for non-invasive measurement of dynamic cardiopulmonary interaction parameters | |
| US20090312652A1 (en) | Electronic manometer for appropriately adjusting internal pressure of cuff and method for controlling the same | |
| US9161695B2 (en) | Apparatus for evaluating vascular endothelial function | |
| CN110840429B (en) | Blood pressure measurement method based on Korotkoff sounds and blood pressure measurement and cardiovascular system evaluation system | |
| KR101037796B1 (en) | Method and apparatus for checking the accuracy of blood pressure measuring devices | |
| US6440080B1 (en) | Automatic oscillometric apparatus and method for measuring blood pressure | |
| JP4289850B2 (en) | Automatic indirect non-invasive device and method for determining diastolic blood pressure by calibrating vibration waveforms | |
| US20130158419A1 (en) | Apparatus for evaluating vascular endothelial function | |
| JP2008513091A (en) | Measurement of blood flow and venous volume | |
| US6793628B2 (en) | Blood-pressure measuring apparatus having augmentation-index determining function | |
| WO2008156377A1 (en) | Method and apparatus for obtaining electronic oscillotory pressure signals from an inflatable blood pressure cuff | |
| JP2022512449A (en) | Control unit for deriving a measure of arterial compliance | |
| JP6854804B2 (en) | Improved blood pressure measurement system | |
| US6746405B2 (en) | Blood pressure measuring apparatus with pulse wave detecting function | |
| TWI511702B (en) | Methods for the measurement of endothelial cell dilatation | |
| JP2023518092A (en) | Blood pressure measurement system and blood pressure measurement method using the same | |
| US6458085B1 (en) | Method and apparatus for oscillometric blood-pressure measurement | |
| JPH08229011A (en) | Blood ejection function-evaluating device | |
| JPH08256999A (en) | Living body information monitoring device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |